Home › Dyax Corp. Announces Expansion Of Phase 1b Clinical Trial For DX-2930
 

Keywords :   


Dyax Corp. Announces Expansion Of Phase 1b Clinical Trial For DX-2930

2014-11-05 07:17:01| drugdiscoveryonline Home Page

Dyax Corp. recently announced the expansion of its ongoing Phase 1b clinical trial evaluating DX-2930 to include additional patients and dosing cohorts

Tags: trial phase corp clinical

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.11LL
16.11 1.2.3.4.5.6.
16.11KTF 21SVTW
16.11 a
16.11 Lord Finesse From The Crates To The File
16.11AB6IX
16.11TOMIX JR EF63()
16.11
More »